| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | somatic recombination of T cell receptor gene segments | 8.84e-05 | 5 | 62 | 2 | GO:0002681 | |
| GeneOntologyBiologicalProcess | T cell receptor V(D)J recombination | 8.84e-05 | 5 | 62 | 2 | GO:0033153 | |
| GeneOntologyBiologicalProcess | somatic diversification of T cell receptor genes | 8.84e-05 | 5 | 62 | 2 | GO:0002568 | |
| Domain | CTNNB1-bd_N | 5.66e-05 | 4 | 58 | 2 | IPR013558 | |
| Domain | CTNNB1_binding | 5.66e-05 | 4 | 58 | 2 | PF08347 | |
| Domain | TCF/LEF | 5.66e-05 | 4 | 58 | 2 | IPR024940 | |
| Domain | Clathrin_mu_CS | 1.41e-04 | 6 | 58 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 1.41e-04 | 6 | 58 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 1.41e-04 | 6 | 58 | 2 | PS00991 | |
| Domain | Mob1_phocein | 1.97e-04 | 7 | 58 | 2 | PF03637 | |
| Domain | MOB_kinase_act_fam | 1.97e-04 | 7 | 58 | 2 | IPR005301 | |
| Domain | - | 1.97e-04 | 7 | 58 | 2 | 1.20.140.30 | |
| Domain | Mob1_phocein | 1.97e-04 | 7 | 58 | 2 | SM01388 | |
| Domain | Clathrin_mu | 4.20e-04 | 10 | 58 | 2 | IPR001392 | |
| Domain | Adap_comp_sub | 5.12e-04 | 11 | 58 | 2 | PF00928 | |
| Domain | Clathrin_sm-chain_CS | 6.13e-04 | 12 | 58 | 2 | IPR000804 | |
| Domain | MHD | 7.23e-04 | 13 | 58 | 2 | PS51072 | |
| Domain | OLF | 7.23e-04 | 13 | 58 | 2 | PS51132 | |
| Domain | MHD | 7.23e-04 | 13 | 58 | 2 | IPR028565 | |
| Domain | Olfac-like_dom | 7.23e-04 | 13 | 58 | 2 | IPR003112 | |
| Domain | OLF | 7.23e-04 | 13 | 58 | 2 | SM00284 | |
| Domain | OLF | 7.23e-04 | 13 | 58 | 2 | PF02191 | |
| Domain | AP_mu_sigma_su | 1.11e-03 | 16 | 58 | 2 | IPR022775 | |
| Domain | Clat_adaptor_s | 1.11e-03 | 16 | 58 | 2 | PF01217 | |
| Domain | C345C | 1.25e-03 | 17 | 58 | 2 | SM00643 | |
| Domain | NTR | 1.57e-03 | 19 | 58 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 1.57e-03 | 19 | 58 | 2 | IPR018933 | |
| Domain | NTR | 2.30e-03 | 23 | 58 | 2 | PS50189 | |
| Domain | Netrin_domain | 2.30e-03 | 23 | 58 | 2 | IPR001134 | |
| Domain | TIMP-like_OB-fold | 2.94e-03 | 26 | 58 | 2 | IPR008993 | |
| Domain | Longin-like_dom | 3.40e-03 | 28 | 58 | 2 | IPR011012 | |
| Domain | Catenin_binding_dom | 3.65e-03 | 29 | 58 | 2 | IPR027397 | |
| Domain | - | 3.65e-03 | 29 | 58 | 2 | 4.10.900.10 | |
| Domain | ZF_CCHC | 5.28e-03 | 35 | 58 | 2 | PS50158 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 1.76e-04 | 6 | 49 | 2 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 1.76e-04 | 6 | 49 | 2 | M47736 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 2.46e-04 | 7 | 49 | 2 | M47465 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 3.27e-04 | 8 | 49 | 2 | MM17229 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 3.27e-04 | 8 | 49 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 3.27e-04 | 8 | 49 | 2 | M27821 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 5.23e-04 | 10 | 49 | 2 | M47486 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 5.23e-04 | 10 | 49 | 2 | MM15156 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M47410 | |
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 1.17e-06 | 12 | 62 | 3 | 10631168 | |
| Pubmed | Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells. | 3.13e-06 | 2 | 62 | 2 | 26490636 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16424171 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 27044748 | ||
| Pubmed | Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. | 3.13e-06 | 2 | 62 | 2 | 8223271 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 30918012 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 37741305 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28366874 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 9462507 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 38169425 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 34615872 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22111711 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 18247340 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 1989880 | ||
| Pubmed | Differential expression of LEF1/TCFs family members in colonic carcinogenesis. | 9.37e-06 | 3 | 62 | 2 | 27433921 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 26107939 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 12731066 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 22875805 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 29186471 | ||
| Pubmed | TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases. | 9.37e-06 | 3 | 62 | 2 | 31216480 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 27111144 | ||
| Pubmed | TCF transcription factors: molecular switches in carcinogenesis. | 1.87e-05 | 4 | 62 | 2 | 10528152 | |
| Pubmed | LEF-1 negatively controls interleukin-4 expression through a proximal promoter regulatory element. | 1.87e-05 | 4 | 62 | 2 | 18579517 | |
| Pubmed | Pja2 Inhibits Wnt/β-catenin Signaling by Reducing the Level of TCF/LEF1. | 1.87e-05 | 4 | 62 | 2 | 30021253 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 23103132 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 23572277 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 26214741 | ||
| Pubmed | Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. | 1.87e-05 | 4 | 62 | 2 | 30837262 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 37303493 | ||
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 1.87e-05 | 4 | 62 | 2 | 17065530 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.18e-05 | 475 | 62 | 7 | 31040226 | |
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 3.12e-05 | 5 | 62 | 2 | 21285352 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 11447280 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 28844837 | ||
| Pubmed | Association analysis between schizophrenia and the AP-3 complex genes. | 3.12e-05 | 5 | 62 | 2 | 19481122 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 37074193 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 35108544 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 29337183 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 9488439 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 23152144 | ||
| Pubmed | SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. | 4.67e-05 | 6 | 62 | 2 | 20128911 | |
| Pubmed | Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. | 4.67e-05 | 6 | 62 | 2 | 24748645 | |
| Pubmed | γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia. | 4.67e-05 | 6 | 62 | 2 | 30991025 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 24836425 | ||
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 4.67e-05 | 6 | 62 | 2 | 19304756 | |
| Pubmed | USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. | 4.67e-05 | 6 | 62 | 2 | 23486064 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 23562159 | ||
| Pubmed | The Wnt/beta-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis. | 6.53e-05 | 7 | 62 | 2 | 16936075 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 30185805 | ||
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 6.53e-05 | 7 | 62 | 2 | 32820720 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 16678815 | ||
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 6.53e-05 | 7 | 62 | 2 | 18772112 | |
| Pubmed | Characterization of the adaptor-related protein complex, AP-3. | 6.53e-05 | 7 | 62 | 2 | 9151686 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 19303461 | ||
| Pubmed | XRN2 SIPA1L1 LRP2 DAAM2 WDFY3 MGAT5B ADAM22 USP33 SCAI BRWD1 | 8.56e-05 | 1285 | 62 | 10 | 35914814 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 26969725 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 19739119 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 9545220 | ||
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 1.12e-04 | 9 | 62 | 2 | 17335794 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 29229772 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 18076669 | ||
| Pubmed | 1.58e-04 | 285 | 62 | 5 | 34369648 | ||
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 21452227 | ||
| Pubmed | Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. | 1.70e-04 | 11 | 62 | 2 | 11731265 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 35132438 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 32414917 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 27713059 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 36449606 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 20805501 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 12490567 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 2.04e-04 | 12 | 62 | 2 | 11266540 | |
| Pubmed | Particularities of the vasculature can promote the organ specificity of autoimmune attack. | 2.41e-04 | 13 | 62 | 2 | 16444258 | |
| Pubmed | 2.81e-04 | 14 | 62 | 2 | 15226261 | ||
| Pubmed | 2.81e-04 | 14 | 62 | 2 | 12433684 | ||
| Pubmed | 2.81e-04 | 14 | 62 | 2 | 33195246 | ||
| Pubmed | Floor-plate-derived netrin-1 is dispensable for commissural axon guidance. | 2.81e-04 | 14 | 62 | 2 | 28445456 | |
| Pubmed | Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. | 2.81e-04 | 14 | 62 | 2 | 10090727 | |
| Pubmed | Phases of canonical Wnt signaling during the development of mouse intestinal epithelium. | 3.23e-04 | 15 | 62 | 2 | 17681174 | |
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 23624311 | ||
| Pubmed | Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. | 3.23e-04 | 15 | 62 | 2 | 15866165 | |
| Pubmed | β-Catenin-SOX2 signaling regulates the fate of developing airway epithelium. | 3.23e-04 | 15 | 62 | 2 | 22421361 | |
| Pubmed | 3.69e-04 | 16 | 62 | 2 | 19557172 | ||
| Pubmed | Hindgut defects and transformation of the gastro-intestinal tract in Tcf4(-/-)/Tcf1(-/-) embryos. | 3.69e-04 | 16 | 62 | 2 | 15057272 | |
| Pubmed | The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. | 3.69e-04 | 16 | 62 | 2 | 21571217 | |
| Pubmed | 3.69e-04 | 16 | 62 | 2 | 23247405 | ||
| Pubmed | 4.18e-04 | 17 | 62 | 2 | 19766620 | ||
| Pubmed | Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. | 4.18e-04 | 17 | 62 | 2 | 17510365 | |
| Pubmed | Different roles of Runx2 during early neural crest-derived bone and tooth development. | 4.18e-04 | 17 | 62 | 2 | 16813524 | |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 4.31e-04 | 197 | 62 | 4 | 29872149 | |
| Pubmed | Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. | 4.70e-04 | 18 | 62 | 2 | 16199891 | |
| Pubmed | 4.70e-04 | 18 | 62 | 2 | 21998198 | ||
| Pubmed | 5.24e-04 | 19 | 62 | 2 | 32290615 | ||
| Pubmed | 5.24e-04 | 19 | 62 | 2 | 22342532 | ||
| Pubmed | Wnt/β-catenin signaling in the dental mesenchyme regulates incisor development by regulating Bmp4. | 5.24e-04 | 19 | 62 | 2 | 20883686 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 5.30e-04 | 1321 | 62 | 9 | 27173435 | |
| Pubmed | Sequential roles of Hedgehog and Wnt signaling in osteoblast development. | 5.82e-04 | 20 | 62 | 2 | 15576404 | |
| Pubmed | Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction. | 5.82e-04 | 20 | 62 | 2 | 22573616 | |
| Pubmed | 5.82e-04 | 20 | 62 | 2 | 28154153 | ||
| Pubmed | 5.82e-04 | 20 | 62 | 2 | 16920270 | ||
| Pubmed | 6.42e-04 | 21 | 62 | 2 | 19806668 | ||
| GeneFamily | MOB kinase activators|STRIPAK complex | 1.05e-04 | 7 | 41 | 2 | 647 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.54e-06 | 265 | 59 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_100 | 2.27e-05 | 3 | 59 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.93e-05 | 336 | 59 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3 | 5.07e-05 | 73 | 59 | 4 | GSM399400_100 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_500 | 6.35e-05 | 28 | 59 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.19e-04 | 173 | 59 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.51e-04 | 182 | 59 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_100 | 1.60e-04 | 38 | 59 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 1.68e-04 | 424 | 59 | 7 | GSM538231_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3 | 1.70e-04 | 425 | 59 | 7 | GSM538282_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 1.91e-04 | 740 | 59 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_200 | 2.10e-04 | 8 | 59 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.17e-04 | 310 | 59 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 2.76e-04 | 778 | 59 | 9 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 3.03e-04 | 47 | 59 | 3 | GSM403995_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 3.30e-04 | 797 | 59 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 3.34e-04 | 336 | 59 | 6 | GSM538413_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_200 | 3.43e-04 | 49 | 59 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_200 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 3.86e-04 | 51 | 59 | 3 | GSM538374_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 4.09e-04 | 52 | 59 | 3 | GSM399382_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 4.09e-04 | 52 | 59 | 3 | GSM538377_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 4.32e-04 | 53 | 59 | 3 | GSM538380_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3 | 4.32e-04 | 53 | 59 | 3 | GSM399370_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.Sp, 4+ 8- 25- 62Lhi 44lo, Spleen, avg-4 | 4.57e-04 | 54 | 59 | 3 | GSM538382_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4int8+.Th, 4int 8+ TCRhi, Thymus, avg-3 | 4.57e-04 | 54 | 59 | 3 | GSM399367_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 4.70e-04 | 130 | 59 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2 | 4.82e-04 | 55 | 59 | 3 | GSM404003_100 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 4.82e-04 | 55 | 59 | 3 | GSM403994_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem44h62l.LN, CD4 TCRb CD44hi CD62Llo, Lymph Node, avg-3 | 4.82e-04 | 55 | 59 | 3 | GSM538368_100 | |
| CoexpressionAtlas | CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1 | 5.09e-04 | 56 | 59 | 3 | GSM403986_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 5.09e-04 | 56 | 59 | 3 | GSM399362_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3 | 5.36e-04 | 57 | 59 | 3 | GSM605763_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3 | 5.36e-04 | 57 | 59 | 3 | GSM399394_100 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 5.64e-04 | 58 | 59 | 3 | GSM403987_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP69+.Th, 4- 8+ TCRhi 69+, Thymus, avg-3 | 5.64e-04 | 58 | 59 | 3 | GSM399385_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.LN, TCRb CD44high CD122lo CD4, Lymph Node, avg-3 | 5.64e-04 | 58 | 59 | 3 | GSM538362_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | 5.93e-04 | 59 | 59 | 3 | GSM399376_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3 | 5.93e-04 | 59 | 59 | 3 | GSM605766_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.Sp, 4+ 8- 25- 44hi 122lo, Spleen, avg-3 | 6.23e-04 | 60 | 59 | 3 | GSM538365_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3 | 6.23e-04 | 60 | 59 | 3 | GSM399379_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24int.Th, 4+ 8- TCRhi 24int, Thymus, avg-3 | 6.23e-04 | 60 | 59 | 3 | GSM399373_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3 | 6.23e-04 | 60 | 59 | 3 | GSM538371_100 | |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | 6.54e-04 | 61 | 59 | 3 | GSM404000_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3 | 6.86e-04 | 62 | 59 | 3 | GSM538395_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 7.47e-04 | 147 | 59 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | 7.53e-04 | 64 | 59 | 3 | GSM538398_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3 | 7.62e-04 | 393 | 59 | 6 | GSM476672_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.LN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 7.87e-04 | 65 | 59 | 3 | GSM538406_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.16e-04 | 721 | 59 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | alpha beta T cells, T.8.Sp.B16, 4- 8+ TCR+ 45+, B16 Melanoma Spleen, avg-3 | 8.23e-04 | 66 | 59 | 3 | GSM605770_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 8.60e-04 | 67 | 59 | 3 | GSM538409_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 8.60e-04 | 67 | 59 | 3 | GSM538414_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 8.67e-04 | 153 | 59 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 9.32e-04 | 156 | 59 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 9.37e-04 | 69 | 59 | 3 | GSM538413_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.Sp, 4- 8+ 25- 62Lhi 44lo, Spleen, avg-3 | 9.37e-04 | 69 | 59 | 3 | GSM538415_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 9.37e-04 | 69 | 59 | 3 | GSM538412_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | 9.73e-04 | 412 | 59 | 6 | GSM538260_500 | |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | 9.77e-04 | 70 | 59 | 3 | GSM605909_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1 | 9.77e-04 | 70 | 59 | 3 | GSM605775_100 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 9.85e-04 | 413 | 59 | 6 | GSM605878_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 9.98e-04 | 414 | 59 | 6 | GSM854271_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 1.02e-03 | 71 | 59 | 3 | GSM605778_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 1.06e-03 | 72 | 59 | 3 | GSM605787_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 1.07e-03 | 420 | 59 | 6 | GSM538252_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3+25+.Sp, 4+ 8- GFP+ 25+, Spleen, avg-3 | 1.10e-03 | 73 | 59 | 3 | GSM399365_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d100.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.10e-03 | 73 | 59 | 3 | GSM605904_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 1.14e-03 | 425 | 59 | 6 | GSM538255_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.16e-03 | 426 | 59 | 6 | GSM605859_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 1.19e-03 | 75 | 59 | 3 | GSM605753_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 1.19e-03 | 75 | 59 | 3 | GSM605758_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 1.19e-03 | 75 | 59 | 3 | GSM538385_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.23e-03 | 168 | 59 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.4int8+.Th, 4int 8+ TCRhi, Thymus, avg-3 | 1.24e-03 | 289 | 59 | 5 | GSM399367_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.24e-03 | 76 | 59 | 3 | GSM538403_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3 | 1.24e-03 | 76 | 59 | 3 | GSM476681_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.25e-03 | 169 | 59 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.26e-03 | 433 | 59 | 6 | GSM605856_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.26e-03 | 595 | 59 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 1.28e-03 | 773 | 59 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 1.29e-03 | 77 | 59 | 3 | GSM538401_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | 1.29e-03 | 77 | 59 | 3 | GSM399391_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.29e-03 | 77 | 59 | 3 | GSM538392_100 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_100 | 1.29e-03 | 77 | 59 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.29e-03 | 77 | 59 | 3 | GSM605894_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.33e-03 | 438 | 59 | 6 | GSM605850_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3 | 1.34e-03 | 78 | 59 | 3 | GSM476678_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.LisOva, CD8+ CD45.1+, Spleen, avg-2 | 1.34e-03 | 78 | 59 | 3 | GSM605907_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-2 | 1.34e-03 | 78 | 59 | 3 | GSM605776_100 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 1.34e-03 | 78 | 59 | 3 | GSM538325_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 1.34e-03 | 78 | 59 | 3 | GSM605756_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.36e-03 | 295 | 59 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 1.39e-03 | 79 | 59 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K2 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 1.39e-03 | 79 | 59 | 3 | GSM476684_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 1.39e-03 | 79 | 59 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K2 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3 | 1.39e-03 | 79 | 59 | 3 | GSM605784_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.39e-03 | 79 | 59 | 3 | GSM538389_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3 | 1.44e-03 | 80 | 59 | 3 | GSM605799_100 | |
| CoexpressionAtlas | EB bone marrow_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.46e-03 | 446 | 59 | 6 | PCBC_ratio_EB bone marrow_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3 | 1.49e-03 | 81 | 59 | 3 | GSM476672_100 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.73e-07 | 191 | 62 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-07 | 194 | 62 | 6 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-07 | 194 | 62 | 6 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|World / shred on cell class and cell subclass (v4) | 1.14e-06 | 132 | 62 | 5 | 14a371fc7e47a45b84f10a939163d030ad967de5 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 2.36e-06 | 153 | 62 | 5 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 2.76e-06 | 158 | 62 | 5 | f433bc189f000efa34e8e09ab32b3fa22bcf64c4 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 162 | 62 | 5 | b877b232f0a879a9058d81ad4730e7846484b7c3 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 162 | 62 | 5 | 7384a4dd38ed68ca02a72df6deff4d34c9694ce1 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.67e-06 | 176 | 62 | 5 | 218a072882d387adbbad6916d7214099c7354465 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-06 | 177 | 62 | 5 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-06 | 185 | 62 | 5 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 187 | 62 | 5 | c0a18ab7d88420e20e478ccdce6a2cb0a60a7824 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 187 | 62 | 5 | 442b7bf6bc17fc2d38bccd678be8994b0ead374f | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 187 | 62 | 5 | fda45c15806f34e45d44bb2e1d144591bc6eaa02 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.61e-06 | 189 | 62 | 5 | 347dea83d0c612341c1ef6e5df5e369520f0a0a4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-06 | 189 | 62 | 5 | da014519d6eb21bc2dc2ed65eafe638b42a068ed | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-Treg|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.78e-06 | 190 | 62 | 5 | 8540f4dee99280109e38b997d9247b176808c51a | |
| ToppCell | BLOOD--(3)_DC_(cDC+pDC)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.14e-06 | 192 | 62 | 5 | e290c55a1321e9e577f49e8ba20501b2c8150044 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.32e-06 | 193 | 62 | 5 | 697518bab1338dc441b2d93b410d957e692f20e6 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 194 | 62 | 5 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 194 | 62 | 5 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 194 | 62 | 5 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.89e-06 | 196 | 62 | 5 | cd23c6a29ead3f3ec23c871e6e30bb8812bf1973 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.89e-06 | 196 | 62 | 5 | 6fb93466e53a12f8292da29b9e4952d453b913c3 | |
| ToppCell | severe-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.89e-06 | 196 | 62 | 5 | 14baf176bce5750ef50d6838b748caf68c151e05 | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Control / Condition, Lineage and Cell class | 8.08e-06 | 197 | 62 | 5 | dad6479caac07c1536f2b3082a51d61ae08beca0 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-06 | 199 | 62 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-06 | 199 | 62 | 5 | a1b127f12fa2057d6f2a976a139301a028a3f957 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 8.49e-06 | 199 | 62 | 5 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 8.70e-06 | 200 | 62 | 5 | 195862a319794e57f0506757ae45ab70200bc5b4 | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells-T_cells_1|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.23e-05 | 118 | 62 | 4 | 461a971f3e8047c727b7c6e00d2d64e97d50c6de | |
| ToppCell | IIH-CD4-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 4.12e-05 | 138 | 62 | 4 | e474a0785a651020156baacbf89c4d2b1e4cc473 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.27e-05 | 147 | 62 | 4 | 463af96748349c8fec2911b353a7e7e4cb072280 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 5.55e-05 | 149 | 62 | 4 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | severe_influenza-NK_CD56bright|severe_influenza / disease group, cell group and cell class (v2) | 6.80e-05 | 157 | 62 | 4 | fabaf54429dd5a899f9192f0d42522109ca36b9b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.14e-05 | 159 | 62 | 4 | 8d958d79f5eb3ab683d1245ae7f4f22a2cefbc55 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.32e-05 | 160 | 62 | 4 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | severe_influenza-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 7.68e-05 | 162 | 62 | 4 | 7137990e6e1473665911e39a22092a05ae25ce74 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.86e-05 | 163 | 62 | 4 | 13f76f2979558f5cd27fbfd1659b413b3cac18f5 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 164 | 62 | 4 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 164 | 62 | 4 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.05e-05 | 164 | 62 | 4 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.05e-05 | 164 | 62 | 4 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 165 | 62 | 4 | 54706631d819f401988e2c733dd6e59401a3585d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 165 | 62 | 4 | 28e3083ab90eb02141f844b7f8a218ec9c43dbf9 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 8.44e-05 | 166 | 62 | 4 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.64e-05 | 167 | 62 | 4 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.64e-05 | 167 | 62 | 4 | b89ebd4906f52b1fe6b6540ec9339284e7caddd2 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.84e-05 | 168 | 62 | 4 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.04e-05 | 169 | 62 | 4 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 169 | 62 | 4 | 81bbdcf1fdf5cad5bfe7a559af196ad0d8e18c35 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 169 | 62 | 4 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.04e-05 | 169 | 62 | 4 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 169 | 62 | 4 | b7db33be24a6a9386e277c2f8949551e4d259305 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-05 | 172 | 62 | 4 | 25bf2551d698237bfd912c2ff067b1600dfb19ca | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.68e-05 | 172 | 62 | 4 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-05 | 172 | 62 | 4 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 9.68e-05 | 172 | 62 | 4 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.68e-05 | 172 | 62 | 4 | 5b1f6d4e09e6465acb80b58846ad387e38b155ab | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.90e-05 | 173 | 62 | 4 | 46dbc51270cc80d6e0b7118c53cec8516b1bb508 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-05 | 173 | 62 | 4 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 174 | 62 | 4 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 174 | 62 | 4 | 6ca9433d398aa3b48ecdc522dd545119e7c77dd4 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 174 | 62 | 4 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 174 | 62 | 4 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 62 | 4 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 176 | 62 | 4 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 176 | 62 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 176 | 62 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 176 | 62 | 4 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 177 | 62 | 4 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 177 | 62 | 4 | 28f2ea29a52de90301e6ba770f407ee4034936d5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 177 | 62 | 4 | 13f22e578728be477b097889af483b1e3f3e18bb | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 177 | 62 | 4 | f069197d39aacf7ad63be13133a6f3fd35d429ac | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 177 | 62 | 4 | f87bbc9403e909bb534eb705bcd2bca83d072cc7 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 178 | 62 | 4 | 934a2a7b35a23b56e34d4d0ef68c271513ef1fe9 | |
| ToppCell | lung|World / shred on tissue and cell subclass | 1.10e-04 | 178 | 62 | 4 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | d9eba884e18a0c89bdc70c194bfe4d62cca164fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 178 | 62 | 4 | 1802ff1c6cb18ee62cfef7270c0971048fae5315 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | 4112ac058e18dedb60e248ca43352fd43f54e77a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 178 | 62 | 4 | 4368d20130e5a08716564c19470b6014f16902ac | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | b2bd45f2fee0b4f7cb9fb7c74109f948d0581785 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | cd0c5f15e6b28ce2208346279ee9503d18d9b27d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | 0f5cf34609df791c8baebfdc6590f6eb4dbe0509 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | 6bad4439a1692332f70135ff446a1048fa4c399d | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | 813d121a45e0416de1f26862851f6f0bda7ba43c | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | 3f6feb4ed7779cf5684f52939350b41d7718c3c6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 178 | 62 | 4 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 179 | 62 | 4 | 466da2bc3bfc534ffe111c8c28ece7a3cfa08051 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 179 | 62 | 4 | f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 179 | 62 | 4 | 8498f94202434b3cb5d84f1a37d3ad191baf664e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 179 | 62 | 4 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 179 | 62 | 4 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 179 | 62 | 4 | 02218c048e4dec0c0a3d63d2abb4feb4c3e82697 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-04 | 180 | 62 | 4 | 5273aa2b939b5c640d708d6ca1812550dff5ec0f | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 180 | 62 | 4 | d6e69ac2bd619557ef62ada684c37a44dc4e3f41 | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; PC3; HT_HG-U133A | 6.86e-07 | 194 | 59 | 7 | 5836_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.20e-05 | 197 | 59 | 6 | 6679_UP | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.23e-05 | 198 | 59 | 6 | 6460_UP | |
| Disease | metabolite measurement | 1.24e-04 | 560 | 59 | 7 | EFO_0004725 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 4.63e-04 | 75 | 59 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | obesity (implicated_via_orthology) | 9.12e-04 | 215 | 59 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | xanthosine measurement | 1.14e-03 | 25 | 59 | 2 | EFO_0010549 | |
| Disease | age at first birth measurement | 1.81e-03 | 120 | 59 | 3 | EFO_0009101 | |
| Disease | age-related macular degeneration, disease progression measurement | 3.07e-03 | 41 | 59 | 2 | EFO_0001365, EFO_0008336 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.53e-03 | 152 | 59 | 3 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNPNLYWYRQAAGRG | 46 | A0A0K0K1B3 | |
| WQRIGDQIKYYRNNP | 256 | Q8NEM8 | |
| TAWGYKNYREQRQLP | 756 | Q9P0K1 | |
| PVVRWLNEQRYYGGG | 1251 | P01024 | |
| YGKQGDYIPRQVRTW | 411 | Q6JQN1 | |
| PWRRAGVKYTNNEAY | 166 | Q9Y2T2 | |
| DYNPRERALYTWNNG | 421 | O95897 | |
| YDWRRAPNENGPYFL | 161 | Q8NCC3 | |
| RYNPRERQLYAWDDG | 376 | Q9NRN5 | |
| NPLLYGWMNSNYRKA | 321 | P49146 | |
| QLYPGWSARDNYGKK | 361 | Q9UJU2 | |
| DVGGQKSLRSYWRNY | 66 | P36404 | |
| PWRRTGVKYTNNEAY | 166 | P53677 | |
| RFQRPQGFEYKSGQW | 1291 | Q9NRD9 | |
| MPYKRNGGYFQQWQL | 386 | Q86T65 | |
| NLGRYWNIGPQKTLY | 606 | Q8NCI6 | |
| GYRTNWGYWNLNPKQ | 411 | Q3V5L5 | |
| GWLGPQQYLSYNSLR | 51 | P55899 | |
| PYYRENKQGWQNSIR | 216 | P55316 | |
| GKFQAYDWGSPVQNR | 301 | P07098 | |
| RNWGNGKRPNLETYY | 266 | Q8TB36 | |
| GNAGINYREWYKPLV | 286 | P57789 | |
| NRYLFWADYGQRPKI | 2201 | P98164 | |
| PNYWIRYGGRQDENR | 396 | Q8IVL5 | |
| YNGRPVLGTQKTYQW | 111 | Q6ZMM2 | |
| VYRGLQERNPENWAY | 246 | Q9BXJ9 | |
| YQSQDQRQGYPIWGK | 2081 | Q7Z442 | |
| LGENYADWYQQKPGQ | 46 | A0A075B6J6 | |
| SQYNGYWPLRGEKVI | 511 | Q9BXP8 | |
| RKFGAQGWNRSYPFN | 4041 | Q9UFH2 | |
| AEWLYSQGKGRAYRP | 246 | Q8IW35 | |
| KYPNYGRRNRSWREL | 801 | Q9NSI6 | |
| YQYRLVGPGQWEGAR | 471 | Q99518 | |
| VLNNQRYGLSPDYWG | 356 | P34947 | |
| TYYNSWKRRAQGRAP | 2151 | Q7Z5N4 | |
| QGAWKELDRNYLNYG | 461 | P05060 | |
| YLNYGEEGAPGKWQQ | 471 | P05060 | |
| DSYPDGNITWYRNGK | 161 | Q13740 | |
| AGGPRYEYRWQDERQ | 91 | Q70IA8 | |
| NNTYWRLRAEPGYGN | 821 | Q9BZF2 | |
| NGSWGYPIYNGTLKR | 96 | Q13835 | |
| YRPLFGYWVIGLQNK | 391 | Q9BYJ4 | |
| RRNRPGTKAQDFYNW | 11 | Q9Y3A3 | |
| YRRAQGWQGLKEYDQ | 311 | Q08752 | |
| DVEPYGYAWQAGLRQ | 976 | O43166 | |
| KYVNGSKWYGRRSRP | 101 | Q9Y2I6 | |
| KTGVDYNWLRNYQNP | 56 | P0DJH9 | |
| GLGNVWRFPYRAYTN | 56 | Q99884 | |
| KYGRNLLSPQRPRYW | 81 | Q96EP0 | |
| FSNLRWYKQDTGRGP | 51 | A0A0B4J240 | |
| NYSRLKPGYRWERQL | 3376 | Q8IZQ1 | |
| GRWNTYIPLHYNKDG | 291 | O95210 | |
| YYIADRLNNDPGWKN | 176 | Q9H0D6 | |
| LRDLPQYGQKQWQSY | 76 | Q8N9R8 | |
| FDYDGKRDRWNGYNP | 161 | O95391 | |
| LGRPKGEYRDYSNDW | 141 | Q9H9C1 | |
| LGAYQLYQDPRNVWG | 51 | Q9NUH8 | |
| QLYPGWSARDNYGKK | 331 | P36402 | |
| DYAKKRGWVLGPNNY | 301 | P48556 | |
| HNGEKLYEWRNYGPG | 246 | Q9BUY5 | |
| QQIKARYYWDFQPQG | 46 | Q86WV1 | |
| GGSYEQYRQFQRRKW | 836 | Q8IWU5 | |
| LPQNIWDNLYSRYGG | 786 | Q8TEY7 | |
| PLQYGWQYRTGRLAD | 91 | Q6P5S2 |